Ann Meulemans

Director/Board Member at Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen

Health Technology

Consumer Services

Commercial Services

Profile

Ann Meulemans is the founder of OCTIMET Oncology NV, which was founded in 2016.
Currently, she is the Director at Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen since 2020.
In the past, she worked as Vice President at Movetis NV from 2007 to 2009.
Dr. Meulemans has a graduate and doctorate degree from the University of Antwerp.

Ann Meulemans active positions

Companies	Position	Start
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium.	Director/Board Member	2020-05-14

All active positions of Ann Meulemans

Former positions of Ann Meulemans

Companies	Position	End
OCTIMET Oncology NV OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands.	Founder	-
Movetis NV Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.	Corporate Officer/Principal	-

See the detail of Ann Meulemans's experience

Training of Ann Meulemans

University of Antwerp

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ann Meulemans's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Movetis NV Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.	Health Technology
OCTIMET Oncology NV OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands.	Health Technology
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium.	Commercial Services

See company connections

Stock Market
Insiders
Ann Meulemans